News

Partner news

20 February 2019

Calypso Biotech BV Secures 20 Million EUR in Series A Financing and Strengthens Team to Develop Anti-IL-15 Therapeutic Antibody for Autoimmune Diseases

Read full story

Partner news

14 February 2019

Vor Biopharma Completes $42 Million Series A Financing Round to Advance Lead Cell Therapy Product Candidate for the Treatment of Acute Myeloid Leukemia

Read full story

Partner news

13 February 2019

New strategic partners join £9.5 million dementia drug discovery collaboration

Read full story

Partner news

24 January 2019

Memebox Closes $35 Million Financing to Fuel Innovation and Accelerate Company Growth

Read full story

Partner news

23 January 2019

Philogen Announces Drug Discovery Collaboration With Johnson & Johnson Innovation

Read full story

Partner news

4 January 2019

Ribon Therapeutics Raises $65 Million to Advance Pipeline of Novel Therapeutics Targeting Cellular Stress Pathways for Cancer

Read full story

Partner news

3 January 2019

E-Scape Bio Appoints Dr. Carrolee Barlow as Chief Medical Officer

Read full story

Partner news

12 December 2018

BiomX Enters Collaboration with Johnson & Johnson Innovation for Discovery of Microbiome-based Biomarkers for IBD

Read full story

Partner news

11 December 2018

Vect-Horus Announces Agreement With Johnson & Johnson Innovation

Read full story

Partner news

29 November 2018

ViaCyte Secures $80 Million Financing to Advance Functional Cures for Insulin-Requiring Diabetes

Read full story

Partner news

5 November 2018

Ad Scientiam announces agreement with Johnson & Johnson Innovation to develop a digital assessment scale for Major Depressive Disorders

Read full story

Partner news

31 October 2018

Arrowhead Pharmaceuticals Announces Closing of Agreements with Janssen

Read full story

Partner news

29 October 2018

Carrot Inc. Raises $25 Million to Commercialize Pivot, the Company's Digital Health Solution for Smoking Cessation

Read full story

Partner news

24 October 2018

Touchlight announces collaboration with Janssen Biotech

Read full story

Partner news

17 October 2018

CuraSen Therapeutics Announces $54.5 Million Series A Financing with Industry Veterans at Helm to Develop Drugs Targeting Novel Mechanism for the Treatment of Neurodegenerative Diseases

Read full story